IAS
HRMY icon

IMA Advisory Services’s Harmony Biosciences HRMY Stock Holding History

IMA Advisory Services’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.97K Buy
54
+19
+54% +$599 ﹤0.01% 1107
2026
Q1 		$980 Sell
35
-5
-13% -$164 ﹤0.01% 779
2025
Q4 		$1.5K Buy
+40
New +$1.31K ﹤0.01% 726

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IMA Advisory Services's HRMY Position: Q2 2026 in Review

IMA Advisory Services increased its Harmony Biosciences (HRMY) stake by 54% in Q2 2026, buying an estimated $599 and bringing the position to 54 shares worth $1.97K. The position accounts for ﹤0.01% of the portfolio, ranked #1107.

IMA Advisory Services first reported a position in HRMY in Q4 2025 and has held it in 3 quarters since. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • IMA Advisory Services held 54 shares of Harmony Biosciences worth $1.97K as of Q2 2026.
  • IMA Advisory Services bought 19 Harmony Biosciences shares in Q2 2026, an estimated $599.
  • Harmony Biosciences made up ﹤0.01% of IMA Advisory Services's portfolio in Q2 2026, its #1107 holding.
  • IMA Advisory Services first reported a position in Harmony Biosciences in Q4 2025 and has held it in 3 quarters since.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on IMA Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.